🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
With open, single/ multiple dosing and dose escalation, phase I clinical tr...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2017-10-19
Trial ID
NCT03374007
This study is a single-arm, phase 2 trial of Geptanolimab in patients with ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2018-09-06
Trial ID
NCT03623581
Treatments Being Tested
This study is a multicenter, dose-escalating phase Ib clinical study to eva...
Status
Unknown
Location
Harbin Medical University Cancer Hospital
Start Date
2019-04-04
Trial ID
NCT03977090
Treatments Being Tested
It is a multi-center, prospective, open-label, two-stage optimized design, ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2018-07-02
Trial ID
NCT03502629
Treatments Being Tested
This study is a multi-center, prospective, open-label, single-arm phase II ...
Status
Unknown
Location
National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2019-05-23
Trial ID
NCT03808857
Treatments Being Tested
An open-label, single-arm, phase II clinical study of anti-PD-1 antibody GB...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2018-10-15
Trial ID
NCT03639181
Treatments Being Tested
Study Design and Investigational Plan: This is an open-label Phase 1/2 stu...
Status
Terminated
Location
Border Medical Oncology Research Unit
Start Date
2018-09-05
Trial ID
NCT03655613
The purpose of this study is to determine the safety, tolerability, and rec...
Status
Completed
Location
Chris O'Brien Lifehouse
Start Date
2017-03-27
Trial ID
NCT03053466
Treatments Being Tested
This study is a multi-center, open-label, dose-finding phase Ib clinical st...
Status
Unknown
Location
Shanghai chest hospital
Start Date
2019-07-23
Trial ID
NCT03976856
Treatments Being Tested